Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
Wave Neuroscience tells committee eTMS showed large symptom drops and may reduce opioid cravings
Summary
Wave Neuroscience and providers described EEG‑guided TMS (eTMS) as a promising treatment for PTSD and substance use disorder, cited an FDA breakthrough designation (Nov. 2024) and reported program metrics including roughly 835 treated patients and a 63% reduction on a PTSD symptom scale in program data; providers asked for state funding and wider deployment.
Wave Neuroscience and contracted treatment providers briefed the Local Government, Public Safety and Veterans Affairs Committee on EEG‑guided transcranial magnetic stimulation (eTMS) and local pilot results for PTSD and substance use disorder.
Dr. Juan, representing Wave Neuroscience, described the clinical process: obtain an EEG brain map, identify disrupted regions via computational analytics, then target those areas with transcranial magnetic…
Already have an account? Log in
Subscribe to keep reading
Unlock the rest of this article — and every article on Citizen Portal.
- Unlimited articles
- AI-powered breakdowns of topics, speakers, decisions, and budgets
- Instant alerts when your location has a new meeting
- Follow topics and more locations
- 1,000 AI Insights / month, plus AI Chat
